Keyphrases
Pulmonary Arterial Hypertension
100%
Early Growth Response Protein 1 (EGR1)
100%
Vascular Remodeling
100%
Neointimal Lesion
55%
Neointimal
33%
Pulmonary Vascular Remodeling
33%
DNA Enzyme
33%
Pulmonary Vascular
22%
Disease Development
22%
DNAzyme
22%
Novel Therapeutics
11%
Transcription Factor
11%
Apoptosis
11%
Rodents
11%
Transforming Growth Factor-β
11%
Interleukin-6
11%
Intravenous Administration
11%
Pharmacological Inhibitors
11%
Disease Progression
11%
Platelet-derived Growth factor-BB (PDGF-BB)
11%
Reduced Expression
11%
Hypertension Management
11%
Inductors
11%
Peroxisome Proliferator-activated Receptor
11%
Right Ventricular Hypertrophy
11%
Pulmonary Vascular Resistance
11%
Oligodeoxynucleotide
11%
Pulmonary Artery
11%
Right Ventricular Function
11%
Right Ventricular Systolic Pressure
11%
Pioglitazone
11%
Vascular Proliferation
11%
Right Ventricular Remodeling
11%
Right Ventricular Afterload
11%
Medicine and Dentistry
Pulmonary Hypertension
100%
Vascular Remodeling
100%
Early Growth Response Factor 1
100%
Downregulation
33%
Disease Course
22%
Deoxyribozyme
22%
Disease Exacerbation
11%
Programmed Cell Death
11%
Heart Ventricle Remodeling
11%
Protein P53
11%
Transforming Growth Factor Beta
11%
Platelet Derived Growth Factor
11%
Interleukin-6
11%
Transcription Factors
11%
Systolic Blood Pressure
11%
Lung Vascular Resistance
11%
Peroxisome Proliferator Activated Receptor
11%
Pulmonary Artery
11%
Afterload
11%
Right Ventricular Hypertrophy
11%
Oligodeoxynucleotide
11%
Pioglitazone
11%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
Vascular Remodeling
100%
Early Growth Response Factor 1
100%
Disease Course
22%
Deoxyribozyme
22%
Disease Exacerbation
11%
Heart Ventricle Remodeling
11%
Protein P53
11%
Platelet Derived Growth Factor
11%
Transforming Growth Factor Beta
11%
Transcription Factors
11%
Peroxisome Proliferator Activated Receptor
11%
Heart Right Ventricle Hypertrophy
11%
Oligodeoxynucleotide
11%
Pioglitazone
11%